Skip to main content
NCBI home page
Springer logoLink to Springer
. 2023 Jul 5;42(10):2919–2920. doi: 10.1007/s10067-023-06692-8

Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study

Falko Tesch 1,✉, Franz Ehm 1, Annika Vivirito 2, Danny Wende 3, Manuel Batram 4, Friedrich Loser 5, Simone Menzer 6, Josephine Jacob 2, Martin Roessler 3, Martin Seifert 1, Barbara Kind 1, Christina König 5, Claudia Schulte 3, Tilo Buschmann 7, Dagmar Hertle 3, Pedro Ballesteros 3, Stefan Baßler 7, Barbara Bertele 5, Thomas Bitterer 6, Cordula Riederer 8, Franziska Sobik 8, Lukas Reitzle 9, Christa Scheidt-Nave 9, Jochen Schmitt 1
PMCID: PMC10497701  PMID: 37405528

Correction to: Clinical Rheumatology 10.1007/s10067-023-06670-0

The Figs. 1 and 2 images of the original published version of the above article were interchanged. Now the Figures have been corrected, and the legends remain unchanged as follows:

Fig. 1.

Fig. 1

Open in a new tab

Flowchart for the selection of the COVID-19 and control groups

Fig. 2.

Fig. 2

Open in a new tab

Forest plot comparing incident rate ratios for any first-onset autoimmune disease 3 to 15 months after SARS-CoV-2 infection by subgroup. The severity of COVID-19 was operationalized as only outpatient care, usual hospital care, and ICU/ventilation-intensive care unit and mechanical ventilation

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Clinical Rheumatology are provided here courtesy of Springer

RESOURCES